Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
IRWD
IRWD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IRWD News
Ironwood (IRWD) Q4 2025 Earnings Call Transcript
Feb 25 2026
NASDAQ.COM
Ironwood Pharmaceuticals Q4 Earnings Miss Expectations
Feb 25 2026
seekingalpha
Ironwood Reports 2025 Financial Highlights and 2026 Guidance
Feb 25 2026
Newsfilter
Trump Announces U.S. Oil Companies to Invest Billions in Venezuela Post-Maduro
Jan 05 2026
Benzinga
Health Care Stocks Mixed as NYSE Health Care Index Edges Up
Jan 02 2026
Yahoo Finance
Intelligent Bio Solutions Plans $10 Million Private Placement, Shares Plunge 19.7%
Jan 02 2026
Benzinga
ChowChow Cloud Reports 29% Revenue Growth in H1 2025
Jan 02 2026
Benzinga
Ironwood Pharmaceuticals Shares Surge Following Drug Price Reduction Enhancing Outlook
Jan 02 2026
Barron's
Ironwood Pharmaceuticals Provides 2026 Guidance, LINZESS Sales Expected to Reach $1.125B to $1.175B
Jan 02 2026
NASDAQ.COM
Ironwood Pharmaceuticals Issues FY26 Guidance, Shares Surge 57.7%
Jan 02 2026
Benzinga
Baidu Inc. Proposes Spinoff of Kunlunxin, Shares Rise 11%
Jan 02 2026
Benzinga
Ironwood Pharmaceuticals Projects 2026 Linzess Sales of $1.125 Billion
Jan 02 2026
Benzinga
NASDAQ 100 Pre-Market Indicator Rises 245.41 to 25,495.26
Jan 02 2026
NASDAQ.COM
Ironwood Pharmaceuticals Projects $475M Revenue for Fiscal 2026
Jan 02 2026
NASDAQ.COM
Ironwood Projects 2026 LINZESS U.S. Sales of $1.125 to $1.175 Billion
Jan 02 2026
Newsfilter
Ironwood Shares Climb Following Resolution of Ferring Lawsuit
Dec 23 2025
SeekingAlpha
Show More News
